ACADIA Pharmaceuticals, Inc. (ACAD)
19.95
+0.06
(+0.30%)
USD |
NASDAQ |
Oct 02, 16:00
19.96
+0.01
(+0.05%)
After-Hours: 20:00
ACADIA Pharmaceuticals Price to Book Value : 2.628 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.628 |
| October 01, 2026 | 2.620 |
| September 30, 2026 | 2.655 |
| September 29, 2026 | 2.664 |
| September 28, 2026 | 2.705 |
| September 25, 2026 | 2.724 |
| September 24, 2026 | 2.922 |
| September 23, 2026 | 3.350 |
| September 22, 2026 | 3.479 |
| September 21, 2026 | 3.477 |
| September 18, 2026 | 3.595 |
| September 17, 2026 | 3.616 |
| September 16, 2026 | 3.628 |
| September 15, 2026 | 3.525 |
| September 14, 2026 | 3.626 |
| September 11, 2026 | 3.666 |
| September 10, 2026 | 3.654 |
| September 09, 2026 | 3.647 |
| September 08, 2026 | 3.633 |
| September 04, 2026 | 3.691 |
| September 03, 2026 | 3.670 |
| September 02, 2026 | 3.811 |
| September 01, 2026 | 3.806 |
| August 31, 2026 | 3.809 |
| August 28, 2026 | 3.835 |
| Date | Value |
|---|---|
| August 27, 2026 | 3.917 |
| August 26, 2026 | 3.897 |
| August 25, 2026 | 4.027 |
| August 24, 2026 | 3.906 |
| August 21, 2026 | 3.886 |
| August 20, 2026 | 3.826 |
| August 19, 2026 | 3.980 |
| August 18, 2026 | 3.976 |
| August 17, 2026 | 3.822 |
| August 14, 2026 | 3.720 |
| August 13, 2026 | 3.739 |
| August 12, 2026 | 3.880 |
| August 11, 2026 | 3.874 |
| August 10, 2026 | 3.872 |
| August 07, 2026 | 3.848 |
| August 06, 2026 | 3.748 |
| August 05, 2026 | 3.794 |
| August 04, 2026 | 3.577 |
| August 03, 2026 | 3.374 |
| July 31, 2026 | 3.408 |
| July 30, 2026 | 3.498 |
| July 29, 2026 | 3.47 |
| July 28, 2026 | 3.427 |
| July 27, 2026 | 3.345 |
| July 24, 2026 | 3.272 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agios Pharmaceuticals, Inc. | 1.847 |
| Biogen, Inc. | 1.723 |
| Insmed, Inc. | 32.02 |
| Arcutis Biotherapeutics, Inc. | 14.33 |
| BioMarin Pharmaceutical, Inc. | 1.750 |
Price to Book Value Related Metrics
| PE Ratio | 8.985 |
| PS Ratio | 3.012 |
| PEG Ratio | 0.1344 |
| Price to Free Cash Flow | 23.55 |
| Price | 19.95 |
| Earnings Yield | 11.13% |
| Market Cap | 3.434B |
| PEGY Ratio | 0.1344 |
| Operating PE Ratio | 39.71 |
| Normalized PE Ratio | 8.985 |